POS0621 DISEASE-SPECIFIC ADVERSE DRUG REACTION PROFILES OF ADALIMUMAB AND ETANERCEPT AS REPORTED BY IMMUNE-MEDIATED INFLAMMATORY DISEASE PATIENTS

Background: null Information on adverse drug reactions (ADRs) is generally clustered for all indications of a drug in the patient information leaflet. However, previous research has shown that participants of the Dutch Biologic Monitor (DBM) that use a biologic for their immune-mediated inflammatory disease (IMID) prefer to receive ADR information tailored to their own biologic an IMID (1). Currently, it is unclear whether the ADR profile of a...